Phase 2a study of CM-101, a CCL24 neutralizing antibody, in patients with non-alcoholic steatohepatitis: a proof-of-concept study
Authors:
- Rifaat SafadiRSRifaat Safadi
- John LawlerJLJohn Lawler
- Revital ArichaRARevital Aricha
- Ilan VakninIVIlan Vaknin
- Scott FriedmanSFScott Friedman
- Adi MorAMAdi Mor
- 20 July 2023
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 78, S119-S120